Advertisement
The Leading Source for Pharmaceutical & Biopharmaceutical Manufacturing News
Subscribe to Pharmaceutical Processing
View Sample

FREE Daily Email Newsletter

Health Law Waivers: Too Complicated to Claim?

October 8, 2014 9:01 am | by RICARDO ALONSO-ZALDIVAR, Associated Press | News | Comments

Millions of Americans may qualify for waivers from the most unpopular part of President Barack Obama's health care overhaul. But getting that exemption could be an ordeal. Community groups are concerned about a convoluted process for waivers from the law's tax penalty on people who remain uninsured.

TOPICS:

Americans Living Longer as Most Death Rates Fall

October 8, 2014 8:55 am | by MIKE STOBBE, AP Medical Writer | News | Comments

Americans are living longer than ever before, according to a new government report filled mostly with good news. U.S. life expectancy inched up again and death rates fell. Rates also dropped or held steady for nearly all the leading causes of death. The one exception: The suicide rate reached its highest point in 25 years.

TOPICS:

Report: Cost of Ebola Could Top $32B

October 8, 2014 8:51 am | by DEB RIECHMANN, Associated Press | News | Comments

The economic impact of the Ebola epidemic could reach $32.6 billion by the end of next year if the disease ravaging Guinea, Liberia and Sierra Leone spreads to neighboring countries in West Africa, the World Bank Group said today.    

TOPICS:
Advertisement

Takeda Appoints New Head of Vaccine Development

October 8, 2014 8:41 am | News | Comments

Takeda Pharmaceuticals International has announced that John Boslego, MD, has been named Senior Vice President and Head of Development for Takeda’s Global Vaccine Business Unit, effective December 1, 2014.        

TOPICS:

Canadian Ebola Vaccine License Holder Moving Ahead with Safety Trial

October 8, 2014 8:37 am | by Helen Branswell, The Canadian Press | News | Comments

With talk turning to the idea that Ebola vaccines and drugs may be needed to quell the West African outbreak, the tiny U.S. company that holds the licence for a Canadian-made vaccine says it is working as fast as it can to get that option tested and ready for use.

TOPICS:

Ebola Training Focuses on Astronaut-Like Gear

October 8, 2014 8:25 am | by LINDSEY TANNER, AP Medical Writer | News | Comments

The serious-faced physicians practice pulling on bulky white suits and helmets that make them look more like astronauts than doctors preparing to fight a deadly enemy. These training sessions at U.S. hospitals on Ebola alert and for health workers heading to Africa can make the reality sink in: Learning how to safely put on and take off the medical armor is crucial.

TOPICS:

US Agent Sued Over Fake Facebook Page in Drug Case

October 7, 2014 3:57 pm | by ALICIA A. CALDWELL, Associated Press ERIC TUCKER, Associated Press | News | Comments

The Drug Enforcement Administration set up a fake Facebook account using photographs and other personal information it took from the cellphone of a New York woman arrested in a cocaine case, to trick her friends and associates into revealing incriminating drug secrets.

TOPICS:

Ebola Escapes Europe's Defenses; Pet Dog Must Die

October 7, 2014 3:47 pm | by BARRY HATTON, Associated Press; CIARAN GILES, Associated Press | News | Comments

Health officials in Spain rushed to contain the Ebola virus Tuesday after it escaped Europe's defenses, quarantining four people at a Madrid hospital where a nursing assistant got infected and even getting a court order to kill the woman's dog. 

TOPICS:
Advertisement

Capsule Filler

October 7, 2014 2:56 pm | by Nikita Ernst, Associate Editor | Product Releases | Comments

The new TEKNA Capsule Filler is a hybrid, combining a sampling of technologies from previous MG2 capsule fillers in one solution. 

MRI Could Be Used to Identify Risk for Dementia

October 7, 2014 9:06 am | Videos | Comments

Swiss researchers found that patterns in MRI brain scans could help diagnose dementia. Plus, new guidance on the watch period for stroke victims.                  

TOPICS:

GlobalData: Ultra-Rapid-Acting Insulin Formulations Will Revolutionize Type 1 Diabetes Treatment Market by 2019

October 7, 2014 9:00 am | News | Comments

Ultra-rapid formulations of the currently marketed rapid-acting insulin analogs have the clear potential to radically change the insulin market over the next five years, according to a director with research and consulting firm GlobalData.  

TOPICS:

Capsugel Expands Lipid Multi-Particulate Technology Offering

October 7, 2014 8:57 am | News | Comments

Capsugel announced today the broad commercial availability of its proprietary lipid multi-particulate (LMP) technology. Capsugel’s LMP technology is an innovative drug-delivery platform with multiple applications – including bioavailability enhancement, taste-masking and modified release – for both pharmaceutical and health and nutrition products.

TOPICS:

Bristol-Myers Squibb Withdraws NDA for Hepatitis C Treatment

October 7, 2014 8:43 am | News | Comments

Bristol-Myers Squibb has decided that it will not pursue FDA approval of the dual regimen of daclatasvir and asunaprevir for the treatment of HCV genotype 1b patients in the United States and has therefore withdrawn its new drug application (NDA) for asunaprevir, an NS3/4A protease inhibitor.

TOPICS:

Why Nation's Top Doctors Say Ebola Won't Spread in US

October 7, 2014 8:37 am | by CONNIE CASS, Associated Press | News | Comments

Ebola has arrived in the United States and people are frightened. The nation's top infectious diseases expert says it's perfectly normal to feel anxious about a virus that kills so fast and is ravaging parts of West Africa.     

TOPICS:

US Health Providers Expand Their Ebola Precautions

October 7, 2014 8:28 am | by DAVID B. CARUSO, Associated Press | News | Comments

There hasn't been a single confirmed case of someone being infected with Ebola on U.S. soil — the one confirmed case here involves a man who contracted the virus overseas. But health care providers are worried enough that they are taking a wide variety of precautions.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading